Tau protein levels showed a slight but statistically significant increase in the MPAN group (approximately 10% higher than in controls), and were markedly elevated in the PKAN group (about 80% higher than in controls). The gene discussed is MAPT; the disease is pantothenate kinase-associated neurodegeneration.